SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001070081-21-000035
Filing Date
2021-10-28
Accepted
2021-10-28 16:02:58
Documents
14
Period of Report
2021-10-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ptct-20211028x8k.htm   iXBRL 8-K 45714
2 EX-99.1 ptct-20211028ex9914df365.htm EX-99.1 187184
3 GRAPHIC ptct-20211028ex9914df365001.jpg GRAPHIC 7374
  Complete submission text file 0001070081-21-000035.txt   379665

Data Files

Seq Description Document Type Size
4 EX-101.SCH ptct-20211028.xsd EX-101.SCH 3030
5 EX-101.LAB ptct-20211028_lab.xml EX-101.LAB 15412
6 EX-101.PRE ptct-20211028_pre.xml EX-101.PRE 9804
7 EXTRACTED XBRL INSTANCE DOCUMENT ptct-20211028x8k_htm.xml XML 4728
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

IRS No.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35969 | Film No.: 211358189
SIC: 2834 Pharmaceutical Preparations